DPIIT recognised startup Government of India
Startup India
Kosido Pharma Private Limited
Kosido Pharma Private Limited - healthcare in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹7.45 Lakh
▲ 3824% YoY
Net loss · FY 2025
₹2.56 Lakh
Net margin -34.4%
EBITDA · FY 2025
-₹2.45 Lakh
EBITDA margin -33%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Kosido Pharma Private Limited
Data last updated:
Kosido Pharma Private Limited is a private limited company based in Kolkata, West Bengal, India, recognised as a startup by DPIIT. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 01 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24290WB2021PTC246102. Its GSTIN is 19AAICK8636P1ZK (West Bengal).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Bishnu Sing Koner and Ravi Dokania.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 113A Acharya Jagadish Chandra Bose Road Room No. R/G/7, Kolkata, West Bengal, India – 700014.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.45 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹2.56 Lakh (net margin -34.4%) and EBITDA of -₹2.45 Lakh (EBITDA margin -33%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years.
Kosido Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0023173).
Company details
CIN U24290WB2021PTC246102
Registration Number 246102
Incorporation Date 01 July 2021
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-WB-10-0023173
Recognitions & Rankings of Kosido Pharma
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-WB-10-0023173
Contact details
Kosido Pharma Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address113A Acharya Jagadish Chandra Bose Road Room No. R/G/7, Kolkata, West Bengal, India – 700014
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Kosido Pharma Private Limited, buy the company report.
Comprehensive company report
Kosido Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Kosido Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kosido Pharma Private Limited, buy the company report.
Financials of Kosido Pharma Private Limited
FY 2025 filings availableKosido Pharma Private Limited reported revenue of ₹7.45 Lakh (up 3824% YoY) for FY 2025.
Revenue · FY 2025
₹7.45 Lakh ▲ 3824%
Net loss · FY 2025
₹2.56 Lakh margin -34.4%
EBITDA · FY 2025
-₹2.45 Lakh margin -33%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 27%
EBITDA CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 45%
Revenue has grown at a compounded annual rate (CAGR) of 27% over three years. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹2.45 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹2.56 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -33% | |||
| Net Profit Margin | -34.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Kosido Pharma Private Limited, buy the company report.
Board of directors of Kosido Pharma Private Limited
Kosido Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bishnu Sing Koner Also directs: K D Life Guard Private Limited | Director | 01 Jul 2021 | 5 Years 4 Months | Current |
| Ravi Dokania Also directs: K D Life Guard Private Limited | Director | 01 Jul 2021 | 5 Years 4 Months | Current |
| Sowmit Kumar Sinha | Director | 01 Jul 2021 | 5 Years 4 Months | Current |
Peer comparison
Kosido Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Adreno Pharmaceuticals Private Limited | ₹7.54 Lakh (FY 2025) | -24.0% | Rohini New, Delhi, India | |||
| Qantas Biopharma Private Limited | ₹7.54 Lakh (FY 2024) | 36.0% | Hisar, Haryana, India | |||
| Kosido Pharma Private Limitedthis company | ₹7.45 Lakh (FY 2025) | -₹2.56 Lakh | -34.4% | 3824.0% | Kolkata, West Bengal, India | |
| Maya Surgicals Private Limited | ₹7.45 Lakh (FY 2025) | -71.0% | New Delhi, Delhi, India | |||
| Esbhi Enterprises (OPC) Private Limited | ₹7.4 Lakh (FY 2023) | Hyderabad, Telangana, India |
To see the full peer comparison of Kosido Pharma Private Limited, buy the company report.
Auditor
Kosido Pharma Private Limited is audited by S.K. AGARWALLA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.K. AGARWALLA & CO. | FY 2023 | 325990E |
Shareholding
The shareholding of Kosido Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Kosido Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kosido Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kosido Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Kosido Pharma Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
Active EPFO establishments
1
GST
Kosido Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAICK8636P1ZK | West Bengal | Active | 08 Aug 2021 |
To see the full GST registrations and return filing status of Kosido Pharma Private Limited, buy the company report.
Recent activity
Kosido Pharma Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Bishnu Sing Koner was appointed as Director on 01 Jul 2021.
AGM
Kosido Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Kosido Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata I.
Appointed
Bishnu Sing Koner was appointed as Director.
Appointed
Ravi Dokania was appointed as Director.
Appointed
Sowmit Kumar Sinha was appointed as Director.
Incorporation
01 Jul 2021
Kosido Pharma Private Limited was registered on 01 Jul 2021 with Roc Kolkata I & aged 5 years 4 months as per MCA records.
Frequently asked questions
Kosido Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 01 July 2021 (5+ years old) and is registered under CIN U24290WB2021PTC246102.
Kosido Pharma has 3 current directors:
- Bishnu Sing Koner - Director
- Ravi Dokania - Director
- Sowmit Kumar Sinha - Director
The latest financial statements of Kosido Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Kosido Pharma is 19AAICK8636P1ZK, registered in West Bengal.
The CIN (Corporate Identification Number) of Kosido Pharma is U24290WB2021PTC246102. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kosido Pharma was incorporated on 01 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Kosido Pharma by revenue are Adreno Pharmaceuticals Private Limited, Qantas Biopharma Private Limited, Maya Surgicals Private Limited, Esbhi Enterprises (OPC) Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Bishnu Sing Koner was appointed as Director on 01 Jul 2021. Ravi Dokania was appointed as Director on 01 Jul 2021. Sowmit Kumar Sinha was appointed as Director on 01 Jul 2021.
Yes, Kosido Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Kosido Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-10-0023173).
The registered office of Kosido Pharma is at 113A Acharya Jagadish Chandra Bose Road Room No. RG7, Kolkata, West Bengal, India – 700014.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages